Summary
• Complementary and alternative medicine encompasses a wide array of interventions, including diets, dietary supplements, and herbal products.
• Scientific evidence does not support a substantial role of special diets in the treatment of the majority of patients with rheumatic disease, but various dietary manipulations may be beneficial when combined with standard medical therapy.
• Long-term safety of dietary and herbal supplements is a legitimate concern and patients should always be cautioned about their use of these products.
• Observed benefits in disease activity owing to short-term trials may be more reflective of the natural history of rheumatic disease rather than true differences in long-term outcome.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Eisenberg D, Kessler R, Foster C, et al. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med 1993;328:246–252.
Eisenberg D, Davis R, Ettner S, et al. Trends in alternative medicine use in the United States, 1990–1997: results from a national survey. JAMA 1998;280:1569–1575.
Barnes P, Powell-Griner E, McFann K, Nahin R. Complementary and alternative medicine use among adults: united states, 2002. Advance Data From Vital and Health Statistics, Centers for Disease Control and Prevention 2004;343:1–20.
National Center for Complementary and Alternative Medicine. Available at: http://nccam.nih.gov/about/almanac/organization/NCCAM.htm.
Committee on the framework for evaluating the safety of dietary supplements. Dietary Supplement, a Framework for Evaluating Safety. National Academies Press, Washington, DC, The 2005.
Rao J, Mihaliak K, Kroenke K, et al. Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med 1999;131:409–416.
Ramsey S, Spencer A, Topolski T, et al. Use of alternative therapies by older adults with osteoarthritis. Arthritis Care Res 2001;45:222–227.
Henderson C, Panush R. Diets, dietary supplements, and nutritional therapies in rheumatic diseases. Rheum Dis Clin North Am 1999;25:937–968.
McDougall J, Bruce B, Spiller G, et al. Effects of very low-fat, vegan diet in subjects with rheumatoid arthritis. J Altern Complement Med 2002;8:71–75.
Felson D. Osteoarthritis of the knee. N Engl J Med 2006;354:841–848.
Clegg D, Reda D, Harris C, et al. Glucosamine, chondroitin sulfate and the two in combination for painful knee osteoarthritis. N Engl J Med 2006;354:795–808.
Arthritis Foundation. Arthritis: The Basic Facts. Arthritis Foundation, Atlanta, GA, 1981.
Stamp L, James M, Cleland L. Diet and rheumatoid arthritis: a review of the literature. Semin Arthritis Rheum 2005;35:77–94.
Panush R, Stroud R, Webster E. Food-induced (allergic) arthritis. Inflammatory arthritis exacerbated by milk. Arthritis Rheum 1986;29:220–226.
Darlington L, Ramsey N, Mansfield J. Placebo-controlled, blind study of dietary manipulation therapy in rheumatoid arthritis. Lancet 1986;1:237–239.
Vegetarian diet: a starter’s guide to a plant based diet. Available at: http://mayoclinic.com/health/vegetarian-diet/HQ01596
Kjeldsen-Kragh J, Borchgrevink C, Mowinkel P, et al. Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet 1991;338:899–902.
Rhen T, Cidlowski, J. Antiinflammatory action of glucocorticoids—new mechanisms for old drugs. Arthritis Foundation 2005;353:1711–1723.
Kronmann N, Green A. Epidemiological studies in the Upernavik district, Greenland: incidence of some chronic diseases 1950–1974. Acta Med Scand 1980;208:401–406.
Gruppo Italiano per lo Studio Della Sopravvivenza nell’Infarto micocarico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447–455.
Kremer J. n-3 Fatty acid supplements in rheumatoid arthritis. Am J Clin Nutr 2000;71:349S-351S.
Ariza-Ariza R, Mestanza-Peralta M, Cardiel M. Omega-3 fatty acids in rheumatoid arthritis: an overview. Semin Arthritis Rheum 1998;6:366–370.
Cleland L, James M, Proudman S. The role of fish oils in the treatment of rheumatoid arthritis. Drugs 2003;63:845–853.
Kris-Etherton P, Harris W, Appel L. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747–2757.
Kris-Etherton P, Taylor D, Yu-Poth S, et al. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 2000;71:179S-188S.
Fujikawa M, Yamashita N, Yamazaki K, et al. Eicosapentaenoic acid inhibits antigen-presenting cell function of murine splenocytes. Immunology 1992;75:330–335.
Kremer J, Lawrence D, Jubiz W, et al. Effects of high-dose fish oil on rheumatoid arthritis after stopping non-steroidal anti-inflammatory drugs. Clinical and immune correlates. Arthritis Rheum 1995;38:1107–1114.
Endres S, Ghorbani R, Kelley V, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989;320:265–271.
Curtis C, Hughes C, Flannery C, et al. n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degredation. J Biol Chem 2000;275:721–724.
Curtis C, Rees S, Little C, et al. Pathological indicators of degradation and inflammation in human osteoarthritis cartilage are abrogated by exposure to n-3 fatty acids. Arthritis Rheum 2002;46: 1544–1553.
Lau C, Morley K, Belch J. Effects of fish oil supplementation on non-steroidal anti-inflammatory requirement in patiens with mild rheumatoid arthritis—a double-blind placebo-controlled trial. Br J Rheumatol 1993;32:982–989.
Geusens P, Wouters C, Nijs J, et al. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study. Arthritis Rheum 1994;37:824–829.
Kremer J, Lawrence D, Jubiz W, et al. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Arthritis Rheum 1990;33:810–819.
Volker D, Firtzgerald P, Major G, et al.. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J Rheumatol 2000;27:2343–2346.
Fortin P, Lew R, Liang M, et al. Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. J Clin Epidemiol 1995;48:1379–1390.
Burr M, Fehily A, Gilbert J, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989;2:757–761.
Leaf A, Jorgensen M, Jacobs A, et al. Do fish oils prevent restenosis after coronary angioplasty? Circulation 1994;90:2248–2257.
Eritsland J, Arnesen H, Gronseth K, et al. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardio 1996;77:31–36.
Montori V, Farmer A, Wollan P, et al. Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care 2000;23:1217–1218.
Department of Health and Human Services, US Food and Drug Administration. Substances affirmed as generally recognized as safe: menhaden oil. Federal Register 1997;62:30751–30757. Available at: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=1997_register&docid= fr05jn97–5.
Office of Nutritional Products, Labeling, and Dietary Supplements, Center for Food Safety and Applied Nutrition, US Food and Drug Administration 2002. Available at: http://www.cfsan.fda.gov/~dms/ds-ltr28.html.
Harris, W, Ginsberg H, Arunakul N, et al. safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk 1997;4:385–391.
US Food and Drug Administration. What you need to know about mercury in fish and shellfish. FDA/CFSAN Consumer Advisory 2004. Available at: http://www.cfsan.fda.gov/~dms/admehg3.html.
Covington, M. Omega-3 fatty acids. Am Fam Physician 2004;70:133–140.
Setty A, Sigal L. Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Semin Arthritis Rheum 2005;34:773–784.
Belch J, Hill A. Evening primrose oil and borage oil in rheumatologic conditions. Am J Clin Nutr 2000;71:352S-356S.
Leventhal L, Boyce E, Zurier R. Treatment of rheumatoid arthritis with gammalinolenic acid. Ann Int Med 1993;119:867–873.
Theander E, Horrobin D, Jacobsson L, et al. Gammalinolenic acid treatment of fatigue associated with primary Sjogren’s syndrome. Scand J Rheumatol 2002;31:72–79.
McAlindon T, Felson D, Zhanf Y, et al. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham study. Ann Intern Med 1996;125:353–359.
Lane N, Gore L, Cummings S, et al. Serum vitamin D levels and incident changes of radiographic hip osteoarthritis. A longitudinal study. Arthritis Rheum 1999;42:854–860.
Merlino L, Curtis J, Mikuls T, et al. Vitamin D is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum 2004;50:72–77.
Peterkosfsky B. Ascorbate requirement for hydroxylation and secretion of procollagen: relationship to inhibition of collagen synthesis in scurvy. Am J Clin Nutr 1991;54:1135S-1140S.
Schwartz E, Oh W, Leveille C. Experimentally induced osteoarthritis in guinea pigs: metabolic responses in articular cartilage to developing pathology. Arthritis Rheum 1981;24:1345–1355.
Kraus V, Huebner J, Stabler T, et al. Ascorbic acid increases the severity of spontaneous knee osteoarthritis in a guinea pig model. Arthritis Rheum 2004;50:1822–1831.
McAlindon T, Jacques P, Zhang Y, et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthris Rheum 1996;39:648–656.
Henrotin Y, Kurz G, Aigner T. Review: oxygen and reactive oxygen species in cartilage degredation: friend or foes? Osteoarthrtitis Cartilage 2005;13:643–654.
Jordan J, De Roos A, Renner J, et al. A case-control study of serum tocopherol levels and the alpha- to gamma-tocopherol ratio in radiographic knee osteoarthritis: the Johnston County Osteoarthritis Project. Am J Epidemiol 2004;159:968–977.
Newman B, Gigout L, Sudre L, et al. Coordinated expression of matrix Gla protein is required during endochondral ossification for chondrocyte survival. J Cell Biol 2001;154:659–666.
Neogi T, Booth S, Zhang Y, et al. Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis Rheum 2006;54:1255–1261.
Kolata G. 2 Top-selling arthritis drugs are found to be ineffective. NY Times. Feb 23, 2006.
Lewis S, Crossman M, Flannelly J, et al. Chondroitin sulphation patterns in synovial fluid in osteoarthritis subset. Ann Rheum Dis 1999;58:441–445.
Kolasinski S. Glucosamine and Chondroitin: Update 2006. Alt Med Alert 2006;9:73–84.
Biggee B, Blinn C, McAlindon T, et al. Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness. Ann Rheum Dis 2006;65: 222–226.
Bassleer C, Henrotin Y, Franchimont P. In vitro evaluation of drugs proposed as chondroprotective agents. Int J Tissue React 1992;14:231–240.
Neil K, Orth M, Coussens P, et al. Effects of glucosamine and chondroitin sulfate on mediators of osteoarthritis in cultured equine chondrocytes stimulated by use of recombinant equine interleukin-1b. Am J Vet Res 2005;66:1861–1869.
Reginster J, Deroisy R, Rovati L, et al. Long-term effects of glucosamine sulphate on osteoarthrtitis progression: a randomized, placebo-controlled clinical trial. Lancet 2001;357:251–256.
Cibere J, Kopee J, Thorne A, et al. Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis. Arthritis Rheum 2004;51:738–745.
Towheed T, Maxwell L, Anastassiades T, et al. Glucosamine therapy for treating osteoarthritis. The Cochrane Database of Systematic Reviews 2005;2:CD002946.
Uebelhart D, Malaise M, Marcolongo R, et al. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind multicenter study versus placebo. Osteoarthritis Cartilage 2004;12:269–276.
Michel B, Stucki G, Frey D, et al. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis Rheum 2005;52:779–786.
Hochberg M. Nutritional supplements for knee osteoarthritis-still no resolution. N Engl J Med 2006;52:858–860.
Weiger W, Smith M, Boon H, et al. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 2002;137:889–903.
Saper R, Kales S, Paquin J, et al. Heavy metal content of ayurvedic herbal medicine products. JAMA 2004;292:2868–2873.
Bent S, Ko R. Commonly used herbal medicines in the United States: a review. Am J Med 2004;116:478–485.
Chrubasik S, Eisenberg E, Balan E, et al. Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study. Am J Med 2000;109:9–14.
Schmid B, Ludtke R, Selbmann H, et al. Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized placebo-controlled, double blind clinical trial. Phytother Res 2001;15:344–350.
Phan P, Sohrabi A, Polotsky A, et al. Ginger extract components suppress induction of chemokine expression in human synoviocytes. J Alt Complement Med 2005;11:149–154.
Altman R, Marcussen K. Effects of ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 2001;44:2531–2538.
Bliddal H, Rosetzsky A, Schlichting P, et al. A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthritis Cartilage 2000;8:9–12.
Tao X, Younger J, Fan F, et al. Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. Arthritis Rheum 2002;46: 1735–1743.
Pattrick M, Heptinstall S, Doherty M. Feverfew in rheumatoid arthritis: a double-blind, placebo controlled study. Ann Rheum Dis 1989;48:547–549.
Henrotin Y, Sanchez C, Deberg M, et al. Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and proinflammatory mediator production by human osteoarthritic chondrocytes. J Rheumatol 2003;30:1825–1834.
Henrotin Y, Deberg M, Cielaard J, et al. Avocado/soybean unsaponifiables prevent the inhibitory effect of osteoarthritic subchondral osteoblasts on aggrecan and type II collagen synthesis by chondrocytes. J Rheumatol 2006;33:1668–1678.
Maheu E, Mazieres B, Valat J-P, et al. Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip. Arthritis Rheum 1998;41:81–91.
Appelboom T, Schuermans J, Verbruggen G, et al. Symptoms modifying effect of avocado/soybean unsaponifiables (ASU) in knee osteoarthritis. Scan J Rheumatol 2001;30:242–247.
Lequesne M, Maheu E, Cadet C, et al. Structural effects of avocado/soybean unsaponifiables on joint-space loss in osteoarthritis of the hip. Arthritis Rheum 2002;47:50–58.
Hong J, Bose M, Ju J, et al. Modulation of arachidonic acid metabolism by curcumin and related b-diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenase. Carcinogenesis 2004;25:1671–1679.
Lev-Ari S, Strier L, Kaznov D, et al. Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells. Rheumatology 2006;45:171–177.
Cheng A, Hsu C, Lin J, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001;21:2895–2900.
Deodhar S, Sethi R, Srimal R. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res 1980;71:632–634.
Satoskar R, Shah S, Shenoy S. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with post-operative inflammation. Int J Clin PharmacolTher Toxicol 1986;24:651–654.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, Totowa, NJ
About this chapter
Cite this chapter
Khaw, K., Kolasinski, S.L. (2008). Complementary and Alternative Therapies. In: Coleman, L.A. (eds) Nutrition and Rheumatic Disease. Nutrition and Health. Humana Press. https://doi.org/10.1007/978-1-59745-403-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-59745-403-2_6
Publisher Name: Humana Press
Print ISBN: 978-1-58829-976-5
Online ISBN: 978-1-59745-403-2
eBook Packages: MedicineMedicine (R0)